Literature DB >> 12957858

Visual-spatial ability in Parkinson's disease.

Gregory P Crucian1, Michael S Okun.   

Abstract

Parkinson's Disease (PD) has traditionally been viewed as primarily a disturbance of motor functioning, typically involving tremor, rigidity, hypokinesia, gait disturbance, and postural instability. More recently, decline in cognitive function has been recognized as a feature of PD. One prominent cognitive symptom of PD involves deficits on tasks of spatial ability. However, findings of visual-spatial deficits in individuals with PD have been inconsistent. There are several methodological issues in this area of research that potentially confound the interpretation of data and need to be taken into consideration, including subject characteristics (e.g., age, sex and education), duration of illness, the current level of disability, the presence of emotional depression, the current level of medications, and the presence of dementia. Further, the tests that have shown visual-spatial deficits in PD are often complex, showing sensitivity to other cognitive processes as well. Another problem in this area of research is the lack of a clear understanding of the brain mechanisms that underlie visual-spatial deficits in PD. One theory of cognitive dysfunction in PD suggests that these cognitive deficits are in some way related to disruption of frontal-basal ganglia neural circuits important in executive functions. However, frontal-basal ganglionic dysfunction does not appear to account entirely for the visual-spatial cognitive deficits seen in PD. Subtle differences in performance on executive function measures appear to dissociate individuals with frontal lobe damage from individuals with PD. Findings from two recent studies indicate that PD is indeed associated with deficits in visual-spatial ability. These findings also indicate that the relationship between visual-spatial ability and frontal-executive function in PD is likely complex, and that the visual-spatial deficits in PD may be sensitive to the sex of the individual with PD.

Entities:  

Mesh:

Year:  2003        PMID: 12957858     DOI: 10.2741/1171

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

1.  Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

Authors:  Emilia J Sitek; Ewa Narozanska; Anna Barczak; Barbara Jasinska-Myga; Michał Harciarek; Małgorzata Chodakowska-Zebrowska; Małgorzata Kubiak; Dariusz Wieczorek; Seweryna Konieczna; Rosa Rademakers; Matt Baker; Mariusz Berdynski; Bogna Brockhuis; Maria Barcikowska; Cezary Zekanowski; Kenneth M Heilman; Zbigniew K Wszolek; Jarosław Slawek
Journal:  Neurocase       Date:  2012-11-05       Impact factor: 0.881

2.  Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.

Authors:  Lilah M Besser; Irene Litvan; Sarah E Monsell; Charles Mock; Sandra Weintraub; Xiao-Hua Zhou; Walter Kukull
Journal:  Parkinsonism Relat Disord       Date:  2016-04-09       Impact factor: 4.891

3.  Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats.

Authors:  Jin-Song Yang; Xiao-Hong Wu; Hao-Gang Yu; Li-Song Teng
Journal:  Inflammopharmacology       Date:  2017-06-02       Impact factor: 4.473

4.  Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis.

Authors:  James Nguyen; Alissa Rothman; Kathryn Fitzgerald; Anna Whetstone; Stephanie Syc-Mazurek; Jannelle Aquino; Laura J Balcer; Elliot M Frohman; Teresa C Frohman; Ciprian Crainiceanu; Meghan Beier; Scott D Newsome; Peter A Calabresi; Shiv Saidha
Journal:  Curr Eye Res       Date:  2018-05-01       Impact factor: 2.424

Review 5.  Cortico-basal ganglia networks subserving goal-directed behavior mediated by conditional visuo-goal association.

Authors:  Eiji Hoshi
Journal:  Front Neural Circuits       Date:  2013-10-21       Impact factor: 3.492

6.  Affective theory of mind in Parkinson's disease: the effect of cognitive performance.

Authors:  Ana-Maria Romosan; Liana Dehelean; Radu-Stefan Romosan; Minodora Andor; Ana Cristina Bredicean; Mihaela Adriana Simu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-30       Impact factor: 2.570

7.  Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study.

Authors:  Shu-Yang Yu; Li-Jun Zuo; Fang Wang; Ze-Jie Chen; Yang Hu; Ya-Jie Wang; Xiao-Min Wang; Wei Zhang
Journal:  BMC Neurol       Date:  2014-05-22       Impact factor: 2.474

8.  Retraining function in people with Parkinson's disease using the Microsoft kinect: game design and pilot testing.

Authors:  Brook Galna; Dan Jackson; Guy Schofield; Roisin McNaney; Mary Webster; Gillian Barry; Dadirayi Mhiripiri; Madeline Balaam; Patrick Olivier; Lynn Rochester
Journal:  J Neuroeng Rehabil       Date:  2014-04-14       Impact factor: 4.262

9.  Deviation of Spatial Representation and Asymmetric Saccadic Reaction Time in Hemi-Parkinson's Disease.

Authors:  Dongfang Shen; Min Li; Ying Zhou; Lixin Liang; Lu Zhang; Wangzikang Zhang; Mingsha Zhang; Yujun Pan
Journal:  Front Aging Neurosci       Date:  2018-03-28       Impact factor: 5.750

10.  Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease.

Authors:  Ane Murueta-Goyena; Rocío Del Pino; Marta Galdós; Begoña Arana; Marian Acera; Mar Carmona-Abellán; Tamara Fernández-Valle; Beatriz Tijero; Olaia Lucas-Jiménez; Natalia Ojeda; Naroa Ibarretxe-Bilbao; Javier Peña; Jesus Cortes; Unai Ayala; Maitane Barrenechea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Ann Neurol       Date:  2020-11-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.